07 times oversubscription on the final day of bidding. The company, which operates in the fast‑growing healthcare equipment segment, raised roughly ₹1,200 crore, positioning it among the largest healthcare IPOs of the fiscal year. The strong demand reflects investors’ confidence in the sector’s long‑term growth prospects, especially as India expands its health‑care infrastructure.
The listing is likely to add weight to the Nifty Healthcare index, which has already outperformed the broader Nifty 50 in the past quarter. Analysts expect a modest bump in the index on debut, while the Sensex may see a neutral reaction given the limited free‑float of the issue. The oversubscription also underscores the continued appetite for equity allocations among retail investors, who have been encouraged by recent SEBI reforms that simplify IPO participation through digital platforms.
For the average salaried investor, the IPO offers a chance to tap into a sector that benefits from government health‑spending plans and an aging population. However, the premium pricing typical of hot issues means that short‑term volatility is possible once the shares start trading. Investors should assess their risk tolerance, consider a diversified exposure to healthcare through mutual funds or ETFs, and keep an eye on post‑listing performance before making a sizeable allocation.